Dr. Candida Fratazzi is a specialist in Clinical Research Rare Diseases, Oncology, and Inflammation. She works with small and medium biotech on biologics, including cell therapy and gene therapy developments. Dr. Fratazzi founded BBCR Consulting in 2009 to actively contribute to ongoing innovation in clinical development developing the Strategic Clinical Innovation Organization (SCIO). Her experience in any stage of drug development includes clinical plans, regulatory strategies, and cost-efficient trial design. She spent twelve years working in basic research at prestigious universities, Harvard University, Tufts University, and Johns Hopkins University (USA) and University College London (UCL), and Imperial College London (UK).